Christopher: I'd like some euros erectimax review Over the past century, such patients - sometimes called "outliers" or "super responders" - have stood out by staging remarkable recoveries, or long-term benefit, from cancer drugs that provide little or no help to others. Little heed has been paid to them because there was no way to know why they fared so well. In most cases, the drugs that helped them were abandoned because they helped too few patients.